Recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1 (MCR1.1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for fulfillment based on availability.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a particular tag, please inform us, and we will prioritize its development.
Synonyms
MCR1.1; LACBIDRAFT_300832; NADH-cytochrome b5 reductase 1; Microsomal cytochrome b reductase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-308
Protein Length
full length protein
Species
Laccaria bicolor (strain S238N-H82 / ATCC MYA-4686) (Bicoloured deceiver) (Laccaria laccata var. bicolor)
Target Names
MCR1.1
Target Protein Sequence
MSGRVEVENIPGQVANLLKNVTAGDLLNVASSPAFLVAAAAIVIAAAFYSKVFNSTRPKP LDPSIWKEFPLQKKNQVSPNTAIYTFKLPHAEDVLGLPIGQHISVSADINGKNIVRSYTP ISRQNARGRFELIIKTYEKGNISRHVASLKIGDTLRVKGPKGNFKYTPGLTAHLGMIAGG TGLAPMIQIVRAILQNPPDRTNITLIYANVNEEDILLRAELDALAMGYESRFNLFYVLNN PPSGWTGGVGFVTKEHIKDLLPNPNESNSKILICGPPPMVTAMKKNLEEIKYPVPNTISK LDDKVFVF
Uniprot No.

Target Background

Function
Recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1 (MCR1.1) functions as an electron donor reductase for cytochrome b5. The cytochrome b5/NADH cytochrome b5 reductase electron transfer system supports the catalytic activity of several sterol biosynthetic enzymes.
Database Links
Protein Families
Flavoprotein pyridine nucleotide cytochrome reductase family
Subcellular Location
Endoplasmic reticulum membrane; Single-pass membrane protein. Mitochondrion outer membrane; Single-pass membrane protein.

Q&A

What is Laccaria bicolor NADH-cytochrome b5 reductase 1 (MCR1.1)?

Laccaria bicolor NADH-cytochrome b5 reductase 1 (MCR1.1) is an enzyme classified under EC 1.6.2.2 that functions in electron transport processes . This protein is encoded by the MCR1.1 gene (ORF name: LACBIDRAFT_300832) in Laccaria bicolor, a symbiotic ectomycorrhizal fungus also known as the "Bicoloured deceiver" . The full-length protein consists of 308 amino acids and is functionally analogous to microsomal cytochrome b reductases in other organisms . MCR1.1 likely plays a crucial role in redox reactions within the fungal metabolism, potentially participating in electron transfer pathways similar to its homologs in other species.

How is recombinant MCR1.1 typically expressed and purified for research applications?

The expression and purification of recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1 typically involves the following methodological approach:

  • Expression System: The full-length protein (amino acids 1-308) is commonly expressed in E. coli bacterial expression systems . The gene is typically cloned into an expression vector that allows for the addition of a His-tag at the N-terminus to facilitate purification.

  • Induction Conditions: After transformation into an appropriate E. coli strain, protein expression is induced under optimized conditions (temperature, time, inducer concentration) that maximize yield while minimizing inclusion body formation.

  • Purification Process:

    • Initial capture is performed using immobilized metal affinity chromatography (IMAC) leveraging the His-tag

    • Further purification may involve ion exchange chromatography and/or size exclusion chromatography

    • Purity is typically assessed via SDS-PAGE, with commercial preparations generally exceeding 90% purity

  • Final Preparation: The purified protein is often lyophilized for stability and long-term storage, and subsequently reconstituted in appropriate buffers for experimental use .

When designing expression studies, researchers should consider that even minimal structural modifications can affect catalytic activity, as observed in homologous systems where relatively small amounts of the reductase are sufficient for maintaining catalytic function .

What are the optimal storage conditions for preserving recombinant MCR1.1 activity?

To maintain optimal activity of recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1, the following storage protocols are recommended:

  • Long-term Storage:

    • Store lyophilized protein at -20°C or -80°C

    • For reconstituted protein, storage in buffer containing 50% glycerol at -20°C or -80°C is recommended

    • Aliquoting is essential to avoid repeated freeze-thaw cycles

  • Short-term Storage:

    • Working aliquots can be stored at 4°C for up to one week

    • Tris-based buffer systems with optimal pH (typically pH 8.0) maintain protein stability

  • Reconstitution Protocol:

    • Prior to opening, briefly centrifuge the vial to bring contents to the bottom

    • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

    • Add glycerol to a final concentration of 5-50% for cryoprotection (50% is commonly used)

  • Critical Considerations:

    • Avoid repeated freeze-thaw cycles, as this significantly decreases enzyme activity

    • Use sterile technique when handling reconstituted protein to prevent contamination

    • When designing long-term storage studies, monitor activity periodically to establish stability profiles specific to your experimental conditions

These storage recommendations are crucial for maintaining enzyme activity, as the catalytic function is highly dependent on the preservation of tertiary structure, which can be compromised by improper storage conditions.

How does MCR1.1 integrate with other components in electron transport systems?

Laccaria bicolor NADH-cytochrome b5 reductase 1 functions within a complex electron transport network, where its primary role involves transferring electrons from NADH to cytochrome b5. Based on research with homologous systems, the integration mechanism follows these principles:

  • Electron Transfer Pathway:

    • MCR1.1 oxidizes NADH to NAD+, accepting electrons

    • These electrons are subsequently transferred to cytochrome b5

    • From cytochrome b5, electrons can be channeled to various acceptor proteins/enzymes

  • Multicomponent Enzyme Systems:

    • MCR1.1 may participate in three-component enzyme systems similar to the mitochondrial amidoxime reducing component (mARC) system identified in mammals

    • These systems typically include: a reductase (like MCR1.1), cytochrome b5, and a substrate-specific enzyme

    • The synergistic action of all three components is essential for catalytic activity

  • Structural Requirements for Integration:

    • Protein-protein interactions between MCR1.1 and cytochrome b5 are likely mediated through complementary surface charges

    • The membrane-anchoring domains of both proteins facilitate co-localization in the same subcellular compartments

    • Even minimal amounts of the reductase can sustain catalytic function in these complexes

This integration capability makes MCR1.1 a potential component in reconstituted enzyme systems for studying various reductive metabolic pathways in vitro, particularly for investigating fungal-specific metabolic processes.

What methodologies are most effective for studying MCR1.1 enzymatic activity?

To effectively study the enzymatic activity of Laccaria bicolor NADH-cytochrome b5 reductase 1, researchers can employ several complementary methodological approaches:

  • Spectrophotometric Assays:

    • NADH oxidation can be monitored by following the decrease in absorbance at 340 nm

    • Cytochrome b5 reduction can be tracked by measuring absorbance changes at 424 nm

    • Kinetic parameters (Km, Vmax) for various substrates can be determined using Michaelis-Menten analysis

  • Reconstitution Systems:

    • In vitro reconstitution with purified cytochrome b5 and substrate-specific enzymes

    • Liposome-based reconstitution to mimic membrane environment

    • Controlled ratios of components to determine optimal stoichiometry for activity

  • Genetic Approaches:

    • siRNA-mediated knockdown to assess function in cellular contexts

    • Heterologous expression in model organisms for in vivo activity studies

    • Site-directed mutagenesis to identify critical residues for catalysis

  • Reaction Monitoring Protocol:

    Assay ComponentConcentrationNotes
    Recombinant MCR1.10.1-1 μMConcentration adjusted based on activity
    NADH10-100 μMSubstrate concentration can be varied for kinetic studies
    Cytochrome b51-10 μMRequired for electron transfer
    Buffer system50-100 mMTypically phosphate or Tris-based, pH 7.0-7.4
    Temperature25-37°COptimized based on specific application
    Monitoring340 nm (NADH)Real-time spectrophotometric monitoring
  • Advanced Analytical Techniques:

    • HPLC analysis of reaction products for complex substrate transformations

    • Mass spectrometry to identify products and intermediates

    • Electrochemical methods to study electron transfer dynamics

When designing activity assays, researchers should consider that even minimal levels of reductase may be sufficient for catalysis, which could complicate knockdown studies and stoichiometric analyses .

How can MCR1.1 be integrated into alternative electron donor systems for cytochrome P450 enzymes?

Recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1 can potentially serve as an alternative electron donor for cytochrome P450 enzymes, based on research with homologous systems. The methodological approach to establish such systems includes:

  • Reconstitution Methodology:

    • Purified components are combined in defined ratios: MCR1.1, cytochrome b5, and the target cytochrome P450

    • Incorporation into lipid bilayers or detergent micelles to mimic membrane environment

    • NADH is used as the electron source instead of the canonical NADPH

  • Electron Flow Pathway:

    • NADH → MCR1.1 → cytochrome b5 → cytochrome P450

    • This alternative pathway can potentially support both the first and second reduction steps required for P450 catalytic cycle

  • Experimental Validation:

    • Activity assays with model P450 substrates (such as was done with benzo[a]pyrene using human P450 1A1)

    • Metabolite profiling using HPLC or LC-MS to confirm product formation

    • Comparison with canonical NADPH-dependent systems to assess relative efficiency

  • Stoichiometric Considerations:

    ComponentOptimal Molar RatioFunction
    Cytochrome P4501Terminal oxidase
    MCR1.11-4Electron donor (reductase)
    Cytochrome b55-10Electron transfer protein
    Phospholipids100-1000Membrane environment

This NADH-dependent system offers several advantages for biotechnological applications, including: (1) utilizing the more stable and economical NADH cofactor, (2) potentially altering product profiles compared to conventional systems, and (3) enabling the study of fungal P450 systems that may naturally prefer NADH-dependent electron transfer chains .

What is the role of MCR1.1 in N-reductive metabolism in Laccaria bicolor?

While the specific role of MCR1.1 in Laccaria bicolor has not been fully characterized, inferences can be made based on homologous NADH-cytochrome b5 reductase systems in other organisms:

  • Potential Metabolic Functions:

    • N-reduction of various nitrogen-containing compounds, including xenobiotics

    • Involvement in detoxification pathways of N-hydroxylated compounds

    • Counteraction of cytochrome P450-mediated N-oxidations

  • Possible Participation in Multi-Component Systems:

    • MCR1.1 may function as part of a three-component enzyme system analogous to the mARC system in mammals

    • This system would require MCR1.1 (reductase), cytochrome b5, and potentially a molybdenum-containing enzyme

    • The synergistic action of all three components would be necessary for N-reductive catalysis

  • Ecological and Physiological Significance:

    • As Laccaria bicolor is an ectomycorrhizal fungus, MCR1.1 may play a role in processing plant-derived nitrogen compounds

    • Could be involved in adaptation to specific soil environments where the fungus forms symbiotic relationships with trees

    • May participate in the metabolism of secondary metabolites relevant to fungal-plant interactions

  • Research Approach for Characterization:

    • Comparative genomics with well-characterized homologs

    • Substrate screening with N-hydroxylated compounds

    • In vitro reconstitution with potential partner proteins

    • Gene knockout or knockdown studies in Laccaria bicolor to assess phenotypic effects

When designing studies to investigate the N-reductive role of MCR1.1, researchers should consider testing model substrates such as amidoximes or N-hydroxyguanidines that have been successfully used to characterize similar enzyme systems in mammals .

How do structural features of MCR1.1 contribute to its subcellular localization and function?

The structural features of Laccaria bicolor NADH-cytochrome b5 reductase 1 significantly influence its subcellular localization and functional capabilities:

  • Membrane Anchoring Domains:

    • The N-terminal region (approximately amino acids 1-30) contains hydrophobic segments that likely serve as membrane anchors

    • The sequence "MSGRVEVENIPGQVANLLKNVTAGDLLNVASSPAFLVAAAAIVIAAAFYSKVFNSTR" suggests a membrane-targeting domain followed by a transmembrane segment

    • These features would target MCR1.1 to specific membrane compartments, similar to how mammalian homologs localize to the endoplasmic reticulum or mitochondrial outer membrane

  • Catalytic Domain Architecture:

    • The catalytic domain likely contains two main functional regions:

      • An FAD-binding domain for cofactor interaction

      • An NADH-binding domain that recognizes and processes the electron donor

    • The catalytic core would be positioned on the cytosolic side of the membrane to access soluble NADH

  • Functional Implications of Topology:

    Structural FeatureLocalizationFunctional Significance
    N-terminal anchorMembrane-embeddedDetermines subcellular targeting
    Catalytic domainCytosolic facingAllows interaction with soluble NADH and cytochrome b5
    Protein-protein interaction surfacesExposed surfacesMediates specific recognition of cytochrome b5
  • Experimental Approaches to Study Structure-Localization Relationships:

    • Fluorescent protein tagging combined with confocal microscopy to visualize localization

    • Deletion mutants to determine the minimal membrane-targeting sequence

    • Domain swapping with homologs to alter localization patterns

    • Protease protection assays to confirm membrane topology

Understanding these structural features is critical for researchers designing experiments with recombinant MCR1.1, as truncation of membrane domains or addition of large tags may alter localization and consequently affect function in cellular contexts .

What are the most common challenges in working with recombinant MCR1.1 and how can they be addressed?

Researchers working with recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1 frequently encounter several challenges that can be systematically addressed through optimized protocols:

  • Protein Solubility Issues:

    • Challenge: The membrane-anchoring domain can cause aggregation during expression and purification.

    • Solution: Express truncated versions lacking the N-terminal hydrophobic region, or use specialized detergents like CHAPS or Triton X-100 during purification. Alternatively, fusion tags like SUMO or MBP can enhance solubility.

  • Activity Loss During Storage:

    • Challenge: Enzymatic activity decreases significantly with repeated freeze-thaw cycles.

    • Solution: Store in small working aliquots at 4°C for short-term use (up to one week) . For long-term storage, maintain at -20°C/-80°C in buffer containing 50% glycerol as cryoprotectant .

  • Reconstitution Challenges:

    • Challenge: Ensuring proper folding after lyophilization.

    • Solution: Reconstitute slowly at 4°C in deionized sterile water to a concentration of 0.1-1.0 mg/mL before adjusting buffer conditions . Monitor activity after reconstitution to confirm functional recovery.

  • Co-factor Stability:

    • Challenge: FAD cofactor can dissociate during purification, leading to activity loss.

    • Solution: Include low concentrations of FAD (1-10 μM) in purification and storage buffers to maintain cofactor association.

  • Troubleshooting Guide for Activity Assays:

    IssuePossible CauseSolution
    Low/No activityCofactor lossSupplement assay with FAD
    Protein denaturationCheck protein integrity by native-PAGE
    Improper reconstitutionOptimize reconstitution protocol
    High backgroundNADH auto-oxidationInclude appropriate controls without enzyme
    Buffer interferenceTest alternative buffer systems
    Poor reproducibilityVariable protein concentrationStandardize protein quantification method
    Batch variabilityUse internal standards for normalization
  • Integration with Partner Proteins:

    • Challenge: Establishing functional interactions with cytochrome b5 and other components.

    • Solution: Optimize component ratios empirically; even minimal levels of reductase may be sufficient for catalysis in properly designed systems .

By anticipating these challenges and implementing the recommended solutions, researchers can significantly improve their success rate when working with recombinant MCR1.1 in diverse experimental contexts.

How can researchers optimize MCR1.1 activity in reconstituted enzyme systems?

Optimizing the activity of Laccaria bicolor NADH-cytochrome b5 reductase 1 in reconstituted enzyme systems requires careful consideration of multiple parameters:

  • Component Stoichiometry Optimization:

    • Systematically vary the molar ratios of MCR1.1:cytochrome b5:terminal enzyme

    • Studies with homologous systems suggest that relatively low levels of reductase can sustain activity when other components are optimized

    • Typical starting ratios: 1:5:1 (reductase:cytochrome b5:terminal enzyme)

  • Membrane Environment Reconstitution:

    • Incorporate appropriate phospholipids (e.g., phosphatidylcholine, phosphatidylethanolamine)

    • Test different lipid compositions to mimic native fungal membranes

    • Methods include liposome preparation, nanodiscs, or detergent micelles

  • Buffer System Optimization:

    ParameterRange to TestNotes
    pH6.5-8.0Test in 0.5 pH unit increments
    Ionic strength50-200 mMNaCl or KCl can be varied
    Divalent cations0-5 mMMg²⁺ or Mn²⁺ may enhance activity
    Reducing agents0-2 mMDTT or β-mercaptoethanol
    Temperature20-37°COptimize based on stability and activity
  • Electron Transfer Efficiency Improvement:

    • Ensure adequate NADH concentration (typically 50-500 μM)

    • Maintain anaerobic conditions when studying oxygen-sensitive reactions

    • Consider addition of superoxide dismutase and catalase to remove reactive oxygen species

  • Methodological Approach to Optimization:

    • Use Design of Experiments (DoE) approaches to efficiently explore parameter space

    • Implement high-throughput screening methods for rapid optimization

    • Employ response surface methodology to identify optimal conditions

  • Validation Strategies:

    • Compare activity with native membrane preparations when available

    • Verify product formation using analytical methods (HPLC, MS)

    • Conduct time-course studies to ensure linearity of reaction rates

When optimizing reconstituted systems containing MCR1.1, researchers should note that even minimal levels of the reductase can be sufficient for catalysis, which may have previously complicated efforts to identify the specific reductase involved in some N-reductive metabolic pathways .

What techniques are most effective for studying protein-protein interactions involving MCR1.1?

To effectively characterize the protein-protein interactions of Laccaria bicolor NADH-cytochrome b5 reductase 1 with its partners (particularly cytochrome b5), researchers can employ several complementary techniques:

  • Spectroscopic Methods:

    • UV-Visible Spectroscopy: Monitoring spectral shifts in cytochrome b5 upon interaction with MCR1.1

    • Fluorescence Resonance Energy Transfer (FRET): Using fluorescently labeled proteins to detect proximity

    • Circular Dichroism (CD): Identifying conformational changes upon complex formation

  • Biochemical Approaches:

    • Co-immunoprecipitation: Using antibodies against MCR1.1 to pull down interaction partners

    • Cross-linking Studies: Employing chemical cross-linkers followed by mass spectrometry

    • Size Exclusion Chromatography: Detecting complex formation by shifts in elution volume

  • Biophysical Techniques:

    • Surface Plasmon Resonance (SPR): Quantifying binding kinetics and affinity

    • Isothermal Titration Calorimetry (ITC): Measuring thermodynamic parameters of binding

    • Analytical Ultracentrifugation: Determining stoichiometry and binding constants

  • Structural Biology Approaches:

    • X-ray Crystallography: Resolving atomic details of protein complexes

    • Cryo-Electron Microscopy: Visualizing larger complexes or membrane-associated assemblies

    • NMR Spectroscopy: Mapping interaction interfaces in solution

  • Experimental Design Considerations:

    TechniqueInformation GainedLimitationsSample Requirements
    SPRKinetics, affinitySurface effectsPurified proteins, one partner immobilized
    FRETIn situ interactionsPotential tag interferenceFluorescently labeled proteins
    Cross-linking/MSInteraction sitesChemical modificationPurified complex or native system
    Co-IPPhysiological relevanceAntibody specificityCell/tissue extracts
  • Molecular Mapping Strategies:

    • Alanine scanning mutagenesis to identify critical interaction residues

    • Domain deletion analysis to define minimal interaction regions

    • Competition assays with peptides corresponding to putative interaction sites

When designing experiments to study MCR1.1 interactions, researchers should consider that relatively low concentrations of reductase can be sufficient for functional interactions, potentially making detection of physical interactions challenging . Additionally, the membrane-anchoring domains may play crucial roles in facilitating interactions through co-localization, so experimental designs that preserve these domains may yield more physiologically relevant results .

How does MCR1.1 from Laccaria bicolor compare functionally to NADH-cytochrome b5 reductases from other organisms?

Functional comparison of Laccaria bicolor NADH-cytochrome b5 reductase 1 with homologous enzymes from other organisms reveals both conserved features and potential specializations:

  • Comparative Functional Analysis:

    OrganismReductase TypeLocalizationKey Functional Aspects
    Laccaria bicolorMCR1.1Likely ER/mitochondrialFungal-specific electron transport
    MammalsCYB5R3ER/mitochondrial outer membraneN-reductive metabolism, P450 support
    Saccharomyces cerevisiaeMcr1pMitochondrialErgosterol biosynthesis involvement
    RatVarious isoformsER/mitochondrial/solubleTissue-specific expression patterns
  • Evolutionarily Conserved Functions:

    • Core electron transfer capability from NADH to cytochrome b5

    • FAD utilization as a cofactor

    • Membrane association via N-terminal anchoring domains

    • Potential involvement in lipid metabolism pathways

  • Specialized Adaptations:

    • MCR1.1 likely evolved specialized functions related to the ectomycorrhizal lifestyle of Laccaria bicolor

    • May participate in unique metabolic pathways involved in fungal-plant symbiosis

    • Could have specific substrate preferences adapted to the ecological niche

  • Catalytic Efficiency Considerations:

    • Similar to mammalian systems, even minimal levels of MCR1.1 may be sufficient for catalytic function

    • The kinetic parameters (Km, kcat) may reflect adaptations to the fungal intracellular environment

    • Redox potential may be optimized for specific electron transfer partners in Laccaria bicolor

  • Methodological Approach to Functional Comparison:

    • Heterologous expression and comparative kinetic analysis

    • Cross-species complementation studies

    • Substrate specificity profiling across homologs

    • Structural comparison of catalytic domains

When designing comparative studies, researchers should consider that while the core catalytic mechanism is likely conserved, the physiological roles and regulatory mechanisms may differ significantly between fungal and mammalian systems, reflecting their distinct evolutionary histories and metabolic requirements .

What role might MCR1.1 play in the symbiotic relationship between Laccaria bicolor and plant hosts?

The potential role of NADH-cytochrome b5 reductase 1 in the symbiotic relationship between Laccaria bicolor and its plant hosts involves several hypothesized functions:

  • Metabolic Support for Symbiosis:

    • MCR1.1 may participate in the metabolism of plant-derived compounds encountered at the symbiotic interface

    • Could be involved in detoxification of defensive compounds produced by the host plant during early colonization stages

    • May support the biotransformation of signaling molecules that regulate symbiotic development

  • Redox Homeostasis at the Interface:

    • As an electron transfer enzyme, MCR1.1 might contribute to maintaining appropriate redox balance during symbiotic interactions

    • Could protect against oxidative stress generated during colonization

    • May participate in redox signaling pathways that coordinate fungal-plant communications

  • Specialized Metabolic Pathways:

    • Potential role in the biosynthesis or modification of fungal metabolites exchanged with the plant host

    • Possible involvement in processing nitrogen compounds in the mycorrhizal interface

    • May support lipid metabolism required for the development of specialized structures like the Hartig net

  • Experimental Approaches to Investigate Symbiotic Roles:

    ApproachMethodologyExpected Insights
    TranscriptomicsRNA-seq during different stages of symbiosisExpression patterns of MCR1.1 during colonization
    Functional GenomicsMCR1.1 knockdown/knockout in Laccaria bicolorPhenotypic effects on symbiotic capacity
    MetabolomicsLC-MS/MS profiling of symbiotic interfacesMetabolic pathways potentially involving MCR1.1
    Localization StudiesImmunolocalization or fluorescent protein taggingSpatial distribution during symbiotic interactions
  • Potential Role in Nutrient Exchange:

    • May indirectly support processes involved in nutrient acquisition from soil

    • Could participate in metabolic pathways that process compounds before exchange with the host

    • Potential involvement in the biosynthesis of metallophores or siderophores for mineral uptake

When designing studies to investigate the symbiotic role of MCR1.1, researchers should consider both direct experimental approaches using genetic manipulation of Laccaria bicolor and comparative analyses across different ectomycorrhizal fungi to identify conserved functions relevant to symbiosis.

How can recombinant MCR1.1 be utilized in biotechnological applications?

Recombinant Laccaria bicolor NADH-cytochrome b5 reductase 1 offers several promising applications in biotechnology, leveraging its electron transfer capabilities:

  • Biocatalysis and Enzymatic Transformations:

    • Alternative Electron Donor System: MCR1.1 can potentially serve as part of an NADH-dependent electron transfer system for cytochrome P450 enzymes, enabling more economical biotransformations compared to NADPH-dependent systems

    • N-Reductive Catalysis: Can be incorporated into reconstituted enzyme systems for the reduction of N-hydroxylated compounds

    • Stereoselective Reductions: Potential application in chiral reductions of pharmaceutical intermediates

  • Biosensor Development:

    • Integration into electrochemical biosensors for NADH detection

    • Component in multi-enzyme biosensors for detecting specific metabolites

    • Potential mediator for electron transfer in bioelectronic applications

  • Metabolic Engineering Applications:

    • Enhanced Bioconversion Processes: Introduction into host organisms to improve electron transfer efficiency in engineered metabolic pathways

    • Optimization Protocol:

      StepConsiderationMethodology
      Expression optimizationCodon optimization for hostSynthetic gene design
      Expression level controlPromoter selection and regulation
      Integration with native systemsPartner protein compatibilityCo-expression with appropriate cytochrome b5
      Pathway enhancementMetabolic bottleneck analysisFlux balance analysis
  • Drug Metabolism Studies:

    • Model system for studying N-reductive drug metabolism

    • Component in reconstituted systems for testing drug biotransformations

    • Comparative system to mammalian NADH-cytochrome b5 reductases for species-specific metabolism studies

  • Protein Engineering Opportunities:

    • Development of chimeric reductases with altered cofactor preferences

    • Creation of fusion proteins with cytochrome b5 for enhanced electron transfer

    • Engineering variants with improved stability or altered substrate specificity

When developing biotechnological applications using MCR1.1, researchers should consider that even minimal levels of the reductase can be sufficient for catalytic function in properly designed systems, potentially allowing for economical use of the enzyme in industrial processes . Additionally, the NADH dependency offers cost advantages over NADPH-dependent systems in large-scale applications.

What are the most appropriate techniques for structural characterization of MCR1.1?

Comprehensive structural characterization of Laccaria bicolor NADH-cytochrome b5 reductase 1 requires a multi-technique approach addressing different levels of protein structure:

  • Primary Structure Analysis:

    • Mass Spectrometry: High-resolution MS for accurate mass determination and verification of full sequence integrity

    • Edman Degradation: N-terminal sequencing to confirm processing of recombinant forms

    • Peptide Mapping: Tryptic digest followed by LC-MS/MS to verify sequence coverage

  • Secondary Structure Determination:

    • Circular Dichroism (CD): Quantification of α-helical, β-sheet, and random coil content

    • Fourier Transform Infrared Spectroscopy (FTIR): Complementary assessment of secondary structural elements

    • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): Identification of solvent-accessible regions

  • Tertiary Structure Elucidation:

    TechniqueResolutionAdvantagesLimitationsSample Requirements
    X-ray CrystallographyAtomic (0.5-3Å)Highest resolutionRequires crystalsHighly purified protein (>95%), 5-10 mg
    NMR SpectroscopyAtomic (structures of domains)Solution state, dynamicsSize limitationsIsotope-labeled protein, 5-20 mg
    Cryo-EMNear-atomic (2-4Å)No crystals neededOften requires larger complexesPurified protein, 100-500 μg
    Small-Angle X-ray Scattering (SAXS)Low (10-20Å)Solution state, flexibilityLow resolutionMonodisperse samples, 50-500 μg
  • Cofactor and Membrane Interaction Analysis:

    • UV-Visible Spectroscopy: Characterization of FAD binding and redox states

    • Fluorescence Spectroscopy: Analysis of protein folding and cofactor environment

    • Electron Paramagnetic Resonance (EPR): Investigation of redox centers

    • Lipid Binding Assays: Characterization of interactions with membrane components

  • Dynamic and Functional Structure Analysis:

    • Molecular Dynamics Simulations: Based on experimental structures to explore conformational flexibility

    • HDX-MS: Mapping conformational changes upon substrate/cofactor binding

    • Site-Directed Spin Labeling (SDSL): Combined with EPR to probe specific structural elements

When planning structural studies of MCR1.1, researchers should consider that the membrane-anchoring domain may complicate crystallization efforts. Strategies could include using truncated constructs of the soluble domain for initial structural determination, followed by techniques like NMR or cryo-EM that can better accommodate the membrane-associated regions .

How can researchers quantitatively assess electron transfer efficiency in MCR1.1-containing systems?

Quantitative assessment of electron transfer efficiency in systems containing Laccaria bicolor NADH-cytochrome b5 reductase 1 requires sophisticated analytical approaches:

When designing quantitative electron transfer studies with MCR1.1, researchers should consider that even minimal levels of reductase can support catalytic function, necessitating careful quantification of all system components for accurate efficiency calculations .

What recent technological developments have enhanced our understanding of NADH-cytochrome b5 reductases?

Recent technological advances have significantly expanded our understanding of NADH-cytochrome b5 reductases, with implications for studying Laccaria bicolor MCR1.1:

  • Advanced Genetic Manipulation Technologies:

    • CRISPR-Cas9 Gene Editing: Enabling precise manipulation of reductase genes in native organisms

    • Conditional Knockout Systems: Development of tissue-specific and inducible knockout mouse lines (like HBN and HBRN) for studying cytochrome b5 and reductase functions in vivo

    • siRNA-Mediated Knockdown: Refined approaches allowing specific reduction of reductase levels to determine minimal functional requirements

  • Structural Biology Breakthroughs:

    • Cryo-Electron Microscopy Advances: Near-atomic resolution structures of membrane-associated proteins without crystallization

    • Integrative Structural Biology: Combining multiple techniques (crystallography, NMR, SAXS, crosslinking-MS) for more complete structural models

    • Time-Resolved Structural Studies: Capturing conformational changes during the catalytic cycle

  • Systems Biology Approaches:

    • Multi-Omics Integration: Combining transcriptomics, proteomics, and metabolomics to understand reductase function in broader cellular contexts

    • Interactome Mapping: Comprehensive identification of protein-protein interactions for cytochrome b5 reductases

    • Flux Analysis: Quantitative assessment of electron flow through different metabolic pathways

  • Methodological Innovations for Functional Studies:

    TechnologyApplication to Reductase StudiesKey Advantage
    NanodiscsReconstitution of membrane proteinsNative-like lipid environment
    Single-Molecule EnzymologyDirect observation of electron transfer eventsEliminates ensemble averaging
    Protein EngineeringCreation of fusion proteins and biosensorsSimplified detection systems
    In-Cell NMRStructural analysis in cellular environmentPhysiologically relevant conditions
  • Computational Advances:

    • Molecular Dynamics Simulations: Extended timescales allowing observation of complete catalytic cycles

    • Quantum Mechanics/Molecular Mechanics (QM/MM): More accurate modeling of electron transfer reactions

    • Deep Learning Approaches: Improved prediction of protein-protein interactions and functional sites

These technological developments have established that reductases like NADH-cytochrome b5 reductase can function as sole electron donors for both first and second reduction steps in cytochrome P450-catalyzed reactions, challenging previous understanding of these systems . They have also clarified that even minimal levels of reductase are sufficient for catalysis, explaining previous difficulties in definitively identifying the specific reductase involved in certain metabolic pathways .

What are the most promising future research directions for MCR1.1 and related enzymes?

Future research on Laccaria bicolor NADH-cytochrome b5 reductase 1 and related enzymes presents several promising directions that could significantly advance our understanding and applications:

  • Symbiotic Function Elucidation:

    • Investigating MCR1.1's role in the establishment and maintenance of ectomycorrhizal symbiosis

    • Exploring how MCR1.1-dependent electron transfer processes contribute to nutrient exchange at the fungal-plant interface

    • Comparing MCR1.1 function across different mycorrhizal fungi to identify conserved symbiotic mechanisms

  • Structural Biology Frontiers:

    • Determining the complete three-dimensional structure of MCR1.1, including membrane-anchoring domains

    • Capturing dynamic conformational changes during the catalytic cycle using time-resolved structural techniques

    • Elucidating the structural basis for protein-protein interactions with cytochrome b5 and other partners

  • Metabolic Network Integration:

    • Mapping the complete electron transfer networks involving MCR1.1 in Laccaria bicolor

    • Identifying all substrate pathways that depend on MCR1.1-mediated electron transfer

    • Investigating the role of MCR1.1 in fungal secondary metabolism

  • Biotechnological Applications Development:

    Application AreaResearch DirectionPotential Impact
    BiocatalysisEngineering MCR1.1 for enhanced electron transferMore efficient biotransformation systems
    BiosensorsDevelopment of MCR1.1-based electrochemical sensorsNovel detection methods for environmental/clinical applications
    Synthetic BiologyIntegration into designer metabolic pathwaysNew routes for production of valuable compounds
    Drug MetabolismComparative studies with mammalian reductasesBetter prediction of xenobiotic metabolism
  • Evolutionary and Ecological Perspectives:

    • Tracing the evolutionary history of cytochrome b5 reductases across fungal lineages

    • Investigating adaptation of MCR1.1 properties to specific ecological niches

    • Exploring the diversity of electron transfer systems in fungi with different lifestyles

  • Methodological Innovations:

    • Development of fungal-specific tools for studying MCR1.1 in vivo

    • Creation of biosensors to monitor electron transfer activities in real-time

    • Establishing high-throughput systems for functional characterization

These research directions collectively represent a comprehensive approach to understanding MCR1.1 from molecular to ecological levels. Particular emphasis should be placed on understanding how this enzyme contributes to the unique metabolic capabilities of Laccaria bicolor as an ectomycorrhizal fungus, potentially revealing new insights into plant-microbe interactions and symbiosis-specific metabolic adaptations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.